200 related articles for article (PubMed ID: 35488235)
21. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
22. The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer.
Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
Oncology; 2023; 101(8):473-480. PubMed ID: 37433283
[TBL] [Abstract][Full Text] [Related]
23. Consolidation/Tumor Ratio on Chest Computed Tomography as Predictor of Postoperative Nodal Upstaging in Clinical T1N0 Lung Cancer.
Moon Y; Park JK; Lee KY; Namkoong M; Ahn S
World J Surg; 2018 Sep; 42(9):2872-2878. PubMed ID: 29450699
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
25. Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
Sayan M; Celik A; Kankoc A; Akarsu I; Aslan MT; Kurtoglu A; Ahmedova G; Tastepe AI
Updates Surg; 2023 Dec; 75(8):2335-2342. PubMed ID: 37382803
[TBL] [Abstract][Full Text] [Related]
26. Novel perspective to evaluate the safety of segmentectomy: clinical significance of lobar and segmental lymph node metastasis in cT1N0M0 lung adenocarcinoma.
Xiao F; Yu Q; Zhang Z; Liu D; Guo Y; Liang C; Wang B; Sun H
Eur J Cardiothorac Surg; 2018 Jan; 53(1):228-234. PubMed ID: 28950357
[TBL] [Abstract][Full Text] [Related]
27. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for lymph node metastasis and surgical scope in patients with cN0 non-small cell lung cancer: a single-center study in China.
Jianlong B; Pinyi Z; Xiaohong W; Su Z; Sainan P; Jinfeng N; Shidong X
J Cardiothorac Surg; 2021 Oct; 16(1):304. PubMed ID: 34663403
[TBL] [Abstract][Full Text] [Related]
31. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of lymph node metastasis in patients with non-small cell lung cancer ≤ 2 cm in size: A monocentric population-based analysis.
Yu X; Li Y; Shi C; Han B
Thorac Cancer; 2018 Jan; 9(1):3-9. PubMed ID: 29034994
[TBL] [Abstract][Full Text] [Related]
33. Lymph node metastasis in clinical stage IA peripheral lung cancer.
Wang L; Jiang W; Zhan C; Shi Y; Zhang Y; Lin Z; Yuan Y; Wang Q
Lung Cancer; 2015 Oct; 90(1):41-6. PubMed ID: 26212683
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer.
Zhao F; Zhen FX; Zhou Y; Huang CJ; Yu Y; Li J; Li QF; Zhu CX; Yang XY; You SH; Wu QG; Qin XY; Liu Y; Chen L; Wang W
BMC Cancer; 2019 May; 19(1):444. PubMed ID: 31088404
[TBL] [Abstract][Full Text] [Related]
35. Extent of Lymph Node Dissection in Patients with Small-Sized Peripheral Non-Small Cell Lung Cancer during Intentional Segmentectomy.
Maniwa T; Ohue M; Shintani Y; Okami J
Ann Thorac Cardiovasc Surg; 2023 Dec; 29(6):271-278. PubMed ID: 37100608
[TBL] [Abstract][Full Text] [Related]
36. Independent risk factors for lymph node metastasis in 2623 patients with Non-Small cell lung cancer.
Xue X; Zang X; Liu Y; Lin D; Jiang T; Gao J; Wu C; Ma X; Deng H; Yu Z; Pan L; Xue Z
Surg Oncol; 2020 Sep; 34():256-260. PubMed ID: 32891339
[TBL] [Abstract][Full Text] [Related]
37. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Segmental Lymph Node Metastasis and Clinical Features in cT1N0M0 Lung Adenocarcinoma.
Sun G; Sun Y; Zou Z; Xu S
Biomed Res Int; 2020; 2020():2842604. PubMed ID: 32149096
[TBL] [Abstract][Full Text] [Related]
39. Selection of Pathological N0 (pN0) in Clinical IA (cIA) Lung Adenocarcinoma by Imaging Findings of the Main Tumor.
Kanamoto Y; Sakao Y; Kuroda H; Sakakura N; Asami M; Saito Y; Kawamura M
Ann Thorac Cardiovasc Surg; 2021 Aug; 27(4):230-236. PubMed ID: 33342931
[TBL] [Abstract][Full Text] [Related]
40. Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China.
Chen B; Xia W; Wang Z; Zhao H; Li X; Liu L; Liu Y; Hu J; Fu X; Li Y; Xu Y; Liu D; Yang H; Xu L; Jiang F
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2771-2777. PubMed ID: 31428933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
